4.7 Article

Pharmacological blockage of transforming growth factor-β signalling by a Traf2-and Nck-interacting kinase inhibitor, NCB-0846

期刊

BRITISH JOURNAL OF CANCER
卷 124, 期 1, 页码 228-236

出版社

SPRINGERNATURE
DOI: 10.1038/s41416-020-01162-3

关键词

-

类别

资金

  1. National Cancer Center Research and Development Fund [26-A-13, 26-A-5, 30-A-2]
  2. Acceleration Transformative Research for Medical Innovation (ACT-MS) program of the Japan Agency for Medical Research and Development (AMED) [16im0210804h0001]
  3. Kobayashi Foundation for Cancer Research
  4. KAKENHI [16K14627, 19H05566]
  5. Japan Society for the Promotion of Science (JSPS) [17H03603]
  6. Foundation for Promotion of Cancer Research in Japan
  7. Princess Takamatsu Cancer Research Fund
  8. Grants-in-Aid for Scientific Research [16K14627, 17H03603] Funding Source: KAKEN

向作者/读者索取更多资源

The small-molecule TNIK inhibitor NCB-0846 has been shown to inhibit TGF-beta signaling and nuclear translocation, thereby preventing EMT in lung cancer cells and reducing metastasis through transcriptional downregulation of TGFBRI expression. This represents a potentially promising approach for the treatment of lung cancer patients.
Background Metastasis is the primary cause of death in cancer patients, and its management is still a major challenge. Epithelial to mesenchymal transition (EMT) has been implicated in the process of cancer metastasis, and its pharmacological interference holds therapeutic promise. Methods Traf2- and Nck-interacting kinase (TNIK) functions as a transcriptional coregulator of Wnt target genes. Given the convergence of Wnt and transforming growth factor-beta (TGF beta) signalling, we examined the effects of a small-molecule TNIK inhibitor (named NCB-0846) on the TGF beta 1-induced EMT of lung cancer cells. Results NCB-0846 inhibited the TGF beta 1-induced EMT of A549 cells. This inhibition was associated with inhibition of Sma- and Mad-Related Protein-2/3 (SMAD2/3) phosphorylation and nuclear translocation. NCB-0846 abolished the lung metastasis of TGF beta 1-treated A549 cells injected into the tail veins of immunodeficient mice. The inhibition of EMT was mediated by suppression of the TGF beta receptor type-I (TGFBR1) gene, at least partly through the induction of microRNAs targeting the TGFBR1 transcript [miR-320 (a, b and d) and miR-186]. Conclusions NCB-0846 pharmacologically blocks the TGF beta/SMAD signalling and EMT induction of lung cancer cells by transcriptionally downregulating TGFBRI expression, representing a potentially promising approach for prevention of metastasis in lung cancer patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer

Yukihiro Yoshida, Masaya Yotsukura, Kazuo Nakagawa, Hirokazu Watanabe, Noriko Motoi, Shun-Ichi Watanabe

Summary: This study found that the locations and the number of stations of the positive lymph nodes were identified as prognostic factors in patients with pN1 NSCLC. The primary mode of recurrence was distant recurrence irrespective of postoperative adjuvant chemotherapy.

THORACIC AND CARDIOVASCULAR SURGEON (2021)

Letter Cell Biology

Pulmonary microinvasive small cell carcinoma with an extensive in-situ component identified after photodynamic therapy for 'squamous cell carcinoma in situ': a case report

Masayuki Ota, Yukio Nakatani, Takahiro Nakajima, Kenzo Hiroshima, Noriko Motoi, Ichiro Yoshino, Jun-ichiro Ikeda

HISTOPATHOLOGY (2021)

Letter Oncology

RB1 loss induced small cell lung cancer transformation as acquired resistance to pembrolizumab in an advanced NSCLC patient

Sayaka Arakawa, Tatsuya Yoshida, Masayuki Shirasawa, Daisuke Takayanagi, Shigehiro Yagishita, Noriko Motoi, Yuichiro Ohe

LUNG CANCER (2021)

Article Oncology

Disease flare of leptomeningeal metastases without radiological and cytological findings after the discontinuation of osimertinib

Toshiaki Takahashi, Hitomi Umeguchi, Akiko Tateishi, Tatsuya Yoshida, Noriko Motoi, Yuichiro Ohe

Summary: When CNS symptoms develop immediately after discontinuation of osimertinib, the possibility of a CNS disease flare should be considered even in the absence of radiological or cytological findings.

LUNG CANCER (2021)

Article Genetics & Heredity

Influence of degree of DNA degradation in formalin-fixed and paraffin-embedded tissue samples on accuracy of genome-wide DNA methylation analysis

Sho Ueda, Satoshi Yamashita, Shun-ichi Watanabe, Mika Wakabayashi, Noriko Motoi, Masayuki Noguchi, Shigeki Sekine, Yukio Sato, Toshikazu Ushijima

Summary: The study assessed the accuracy of measuring DNA in formalin-fixed and paraffin-embedded tissue samples using the Infinium MethylationEPIC BeadChip assay. Results showed that the correlation coefficient decreased with DNA degradation, even when meeting quality control standards. Exclusion of specific probes improved correlation, regardless of tissue type, suggesting potential for assay accuracy improvement.

EPIGENOMICS (2021)

Review Cell Biology

Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint

Erik Thunnissen, Noriko Motoi, Yuko Minami, Daisuke Matsubara, Wim Timens, Yukio Nakatani, Yuichi Ishikawa, Ximena Baez-Navarro, Teodora Radonic, Hans Blaauwgeers, Alain C. Borczuk, Masayuki Noguchi

Summary: This review summarises the use of elastin staining in pulmonary pathology, focusing especially on the interpretation of elastin staining in pulmonary adenocarcinomas and the distinction between iatrogenic collapse and alveolar collapse.

HISTOPATHOLOGY (2022)

Article Oncology

Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas

Rintaro Noro, Kazufumi Honda, Kengo Nagashima, Noriko Motoi, Shinobu Kunugi, Jun Matsubayashi, Susumu Takeuchi, Hideaki Shiraishi, Tetsuya Okano, Ayumi Kashiro, Xue Meng, Yukihiro Yoshida, Shunichi Watanabe, Jitsuo Usuda, Tatsuya Inoue, Huang Wilber, Norihiko Ikeda, Masahiro Seike, Akihiko Gemma, Kaoru Kubota

Summary: This study aimed to provide predictive biomarkers for selecting postoperative adjuvant chemotherapy. The results showed that ACTN4 gene amplification was associated with better recurrence-free survival in the adjuvant chemotherapy group in patients aged 65 or older.

CANCER SCIENCE (2022)

Article Oncology

Influences of intratumoral heterogeneity on assessment of tumor microenvironment in esophageal squamous cell carcinoma

Kotaro Sugawara, Takashi Fukuda, Yutaka Kishimoto, Daiji Oka, Takako Yoshii, Hiroki Hara, Yukari Uemura, Yoshiyuki Kawashima, Hiroaki Kanda, Noriko Motoi

Summary: This study investigated the intratumoral heterogeneity (ITH) and the potential of tumor surface in representing the tumor microenvironment (TME) in esophageal squamous cell carcinoma (ESCC). The results showed significant differences in ITH among ESCC specimens, and the tumor surface had high capabilities in predicting the CD8 and PD-L1 status of the whole tumor.

CANCER SCIENCE (2023)

Review Cell Biology

Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine

Eiichi Morii, Yutaka Hatanaka, Noriko Motoi, Akihiko Kawahara, Shinji Hamakawa, Takeshi Kuwata, Tadasuke Nagatomo, Yoshinao Oda, Aikou Okamoto, Ryota Tanaka, Akira Iyoda, Maeda Ichiro, Yukiko Matsuo, Nobuyuki Nakamura, Tokiko Nakai, Mei Fukuhara, Kazuya Tokita, Tomohiko Yamaguchi, Masataka Takenaka, Ayako Kawabata, Kanako C. Hatanaka, Kaho Tsubame, Yukitoshi Satoh

Summary: With the advancement of cancer drug therapy, personalized medicine is becoming more common. Genomic testing is often performed using pathological tissue from malignant tumors, while cytological specimens fixed in alcohol are preferred for preserving nucleic acid quality and quantity. This article shares information on the proper handling of cytological specimens in genomic medicine based on guidelines published by the Japanese Society of Clinical Cytology. The guidelines provide practical advice on specimen handling, including fixation, preparation, and evaluation.

PATHOBIOLOGY (2023)

Article Pathology

Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma

Masahiro Higashiyama, Noriko Motoi, Masaya Yotsukura, Yukihiro Yoshida, Kazuo Nakagawa, Shigehiro Yagishita, Masayuki Shirasawa, Tatsuya Yoshida, Kouya Shiraishi, Takashi Kohno, Yuichiro Ohe, Shun-ichi Watanabe

Summary: Ciliated muconodular papillary tumor/bronchiolar adenoma (CMPT/BA) is a recently introduced benign lung tumor. This study aimed to investigate the clinicopathological characteristics and genetic profiles of coexisting primary lung cancer and CMPT/BA (LCCM) cases. Eight LCCM cases were identified, showing differences in gene mutation profiles between CMPT/BA and lung cancer, suggesting independent clonal tumorigenesis.

PATHOLOGY INTERNATIONAL (2023)

Article Biochemistry & Molecular Biology

Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma

Kiyohiro Ando, Ryo Kurashina, Noriko Motoi, Toshihiko Iizuka, Masaharu Inoue, Riko Maruyama, Kouki Mitani, Hisanori Takenobu, Masayuki Haruta, Ritsuko Onuki, Yoh Matsuoka, Takehiko Kamijo, Yukio Kageyama

Summary: Our study found a significant correlation between low hemoglobin levels and high platelet-to-lymphocyte ratio (PLR) and overall survival in UC patients who did not benefit from Pembrolizumab treatment. We also identified a possible link between PDGF-DD-induced STAT3 activation and these unfavorable prognostic indicators in UC. By inhibiting STAT3 and detecting PDGF-DD in the tumor microenvironment, we suggest a potential therapeutic strategy to overcome resistance to Pembrolizumab.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Article Oncology

Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy

Tomohiro Tanaka, Yasushi Goto, Masafumi Horie, Ken Masuda, Yuki Shinno, Yuji Matsumoto, Yusuke Okuma, Tatsuya Yoshida, Hidehito Horinouchi, Noriko Motoi, Yasushi Yatabe, Shunichi Watanabe, Noboru Yamamoto, Yuichiro Ohe

Summary: This study investigates somatic single-nucleotide variants or copy number variations in exceptional responders to pemetrexed treatment using whole-exome sequencing. The results suggest that exceptional responders may have a higher number of copy number variations. This study provides important insights into the mechanism of exceptional responses and contributes to genomic findings on thymomas and chemosensitivity.

CANCERS (2023)

Article Oncology

Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

Kazunori Aoki, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi, Etsuko Fujii, Takashi Nishizawa, Hironori Fukuda, Kana Ohashi, Kosuke Arai, Yukihiro Mizoguchi, Yukihiro Yoshida, Shun-ichi Watanabe, Makiko Yamashita, Shigehisa Kitano, Hiromi Sakamoto, Yuki Nagata, Risa Mitsumori, Kouichi Ozaki, Shumpei Niida, Yae Kanai, Akiyoshi Hirayama, Tomoyoshi Soga, Toru Maruyama, Keisuke Tsukada, Nami Yabuki, Mei Shimada, Takehisa Kitazawa, Osamu Natori, Noriaki Sawada, Atsuhiko Kato, Teruhiko Yoshida, Kazuki Yasuda, Hideaki Mizuno, Hiroyuki Tsunoda, Atsushi Ochiai

Summary: This study analyzed the TIL profiles of 281 NSCLC tissues and classified NSCLC into three subtypes based on TIL status, which were significantly correlated with patient prognosis. Integrated genomic and transcriptomic analyses revealed subtype-specific molecular pathways and genomic alterations that should play important roles in constructing immune tumor microenvironments. These classifications based on TIL status are useful for developing personalized immune therapies for NSCLC.

CANCER RESEARCH COMMUNICATIONS (2023)

Article Pathology

Prevalence and diagnostic significance of non-invasive follicular thyroid neoplasm with papillary-like nuclear features in Japan-A multi-institutional study

Mitsuyoshi Hirokawa, Masahiro Ito, Noriko Motoi, Tomohiro Chiba, Yoshiaki Imamura, Hironao Yasuoka, Rumi Hino, Miyoko Higuchi, Akira Miyauchi, Takashi Akamizu

Summary: This multi-institutional study investigated the frequency and diagnostic significance of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in Japan. The study found that NIFTP was more common in follicular thyroid adenoma (FTA) than in non-invasive encapsulated follicular variant of papillary thyroid carcinoma (PTC). Additionally, NIFTP with nuclear score 3 showed potential for metastasis and BRAFV600E mutation.

PATHOLOGY INTERNATIONAL (2023)

暂无数据